Shirô Shigeta
- Epidemiology top 1%
- Infectious Diseases top 0.5%
- Molecular Biology top 5%
- Virology top 0.5%
- Organic Chemistry top 2%
- Co-authors
- Erik De ClercqMasanori BabaTomoyuki YokotaMitsuaki HosoyaAkihiko SatoK KonnoMasaru UbasawaRudi Pauwels
- Topics
- HIV/AIDS drug development and treatment (66 papers)HIV Research and Treatment (51 papers)Herpesvirus Infections and Treatments (36 papers)
- Partner nations
- JapanBelgiumUnited States
In The Last Decade
Shirô Shigeta
215 papers receiving 6.1k citations
Peers
Comparison fields: 5 of 138
- Epidemiology 2.3k
- Infectious Diseases 2.2k
- Molecular Biology 1.8k
- Virology 1.3k
- Organic Chemistry 1.1k
Countries citing papers authored by Shirô Shigeta
This map shows the geographic impact of Shirô Shigeta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shirô Shigeta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shirô Shigeta more than expected).
Fields of papers citing papers by Shirô Shigeta
This network shows the impact of papers produced by Shirô Shigeta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shirô Shigeta. The network helps show where Shirô Shigeta may publish in the future.
Co-authorship network of co-authors of Shirô Shigeta
This figure shows the co-authorship network connecting the top 25 collaborators of Shirô Shigeta. A scholar is included among the top collaborators of Shirô Shigeta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shirô Shigeta. Shirô Shigeta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Antiviral Effect of NMSO3 against Adenovirus in Vitro | 1 |
| 2 | 15 | |
| 3 | 64 | |
| 4 | 6 | |
| 5 | 69 | |
| 6 | 8 | |
| 7 | 12 | |
| 8 | 34 | |
| 9 | 2 | |
| 10 | 143 | |
| 11 | Highly potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by the HIV-1-specific reverse transcriptase inhibitors | 13 |
| 12 | 9 | |
| 13 | 154 | |
| 14 | Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987) | 3 |
| 15 | 3 | |
| 16 | 0 | |
| 17 | 2 | |
| 18 | 1 | |
| 19 | 1 | |
| 20 | 1 |
About Shirô Shigeta
Shirô Shigeta is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 218 papers that have together received 6.4k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (66 papers), HIV Research and Treatment (51 papers) and Herpesvirus Infections and Treatments (36 papers). The work is most often cited by research in Virology (1.3k citations), Infectious Diseases (2.2k citations) and Epidemiology (2.3k citations). Shirô Shigeta has collaborated with scholars based in Japan, Belgium and United States. Frequent co-authors include Erik De Clercq, Masanori Baba, Tomoyuki Yokota, Mitsuaki Hosoya, Akihiko Sato, K Konno, Masaru Ubasawa, Rudi Pauwels, Richard Walker and Hideaki Takashima. Their work appears in journals such as New England Journal of Medicine, Nature Biotechnology and PEDIATRICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.